Status:
COMPLETED
Axillary Nodal Burden in HER2+ and TNBC
Lead Sponsor:
Gangnam Severance Hospital
Conditions:
Breast Cancer
Eligibility:
FEMALE
19+ years
Brief Summary
This study aimed to evaluated rates of pathologic axillary nodal metastasis in patients with with early-stage HER2-positive BC or TNBC who had clinically node-negative status on preoperative ultrasono...
Eligibility Criteria
Inclusion
- HER2-positive breast cancer or TNBC
- Patients who received upfront breast conserving surgery with axillary surgery
- Patients who had a clinically axillary node negative disease
Exclusion
- Patients who underwent mastectomy
- Absence of axillary nodal assessment on ultrasonography
- Patients who underwent mastectomy
- Patients who underwent mastectomy
Key Trial Info
Start Date :
June 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2025
Estimated Enrollment :
1571 Patients enrolled
Trial Details
Trial ID
NCT07211451
Start Date
June 1 2025
End Date
September 30 2025
Last Update
October 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gangnam Severance Hospital, Yonsei University College of Medicine
Seoul, Please Select, South Korea, 06273